207 related articles for article (PubMed ID: 14980105)
1. [Enhancement of a hepatitis B DNA vaccine potency using aluminum phosphate in mice].
Liang ZW; Ren H; Lang YH; Li YG
Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):79-81. PubMed ID: 14980105
[TBL] [Abstract][Full Text] [Related]
2. [Construction of eukaryotic expression plasmids inserting HBsAg gene and DNA immunization responses to HBsAg in mice].
Liang Z; Lan Y; Li Y; Cai D; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):106-8. PubMed ID: 11983125
[TBL] [Abstract][Full Text] [Related]
3. [Effect of interleukin-12 on HBV pan-S gene vaccine].
Tan DM; Yang YF; Liu SP
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Feb; 29(1):47-9. PubMed ID: 16137004
[TBL] [Abstract][Full Text] [Related]
4. [Antivirus effect of plasmid co expressing hepatitis B surface antigen and granulocyte macrophage-colony stimulating factor].
Qing YL; Zhao JJ; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2004 Apr; 12(4):201-4. PubMed ID: 15099465
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the adjuvanticity of aluminum salts and their combination in hepatitis B recombinant protein vaccine in assessed mice.
Mahboubi A; Fazeli MR; Dinarvand R; Samadi N; Sharifzadeh M; Ilka H; Azadi S; Soleimanian R; Kalkouei H; Hajikhanmirzaei R; Valadkhani M
Iran J Immunol; 2008 Sep; 5(3):163-70. PubMed ID: 18791283
[TBL] [Abstract][Full Text] [Related]
6. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
[TBL] [Abstract][Full Text] [Related]
7. [HBsAg expression, anti-HBs induction and pathological observation in the mice inoculated with DNA vaccine against hepatitis B].
Zhao L; Qin S; Tang H
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Mar; 13(1):51-3. PubMed ID: 12759954
[TBL] [Abstract][Full Text] [Related]
8. [Immunization with targeted fusion anticaries DNA vaccine via intramuscular route:experiment with murine].
Yu F; Fan MW; Xu QA; Jia R; Guo JH; Bian Z; Chen Z; Peng B; Fan B
Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):754-9. PubMed ID: 15200917
[TBL] [Abstract][Full Text] [Related]
9. [Reciprocal priming-boosting role of HBsAg and DNA vaccines].
Zhou Z; Chen WS; Zhang HH; Yao JL
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):212-4. PubMed ID: 12716517
[TBL] [Abstract][Full Text] [Related]
10. [Specific cellular and humoral immune responses induced by intramuscular injection of DNA vaccine containing HBV HBsAg gene in mice].
Liu S; Tan D; Li C
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):313-5. PubMed ID: 12080633
[TBL] [Abstract][Full Text] [Related]
11. [Specific immune responses in Balb/c mice induced by plasmid coexpressing hepatitis B surface antigen and granulocyte-macrophage colony stimulating factor].
Qing YL; Ling N; Zhao JJ; Peng ML; Xu HM; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):474-6. PubMed ID: 12939179
[TBL] [Abstract][Full Text] [Related]
12. Cationic polymers that enhance the performance of HbsAg DNA in vivo.
Bos GW; Kanellos T; Crommelin DJ; Hennink WE; Howard CR
Vaccine; 2004 Dec; 23(4):460-9. PubMed ID: 15530694
[TBL] [Abstract][Full Text] [Related]
13. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine.
Li X; Yang X; Li L; Liu H; Liu J
Vaccine; 2006 Apr; 24(16):3321-31. PubMed ID: 16472546
[TBL] [Abstract][Full Text] [Related]
14. [Induction of specific humoral immune response in mice by recombinant mutant HBV s gene vaccine].
Ge JH; Liu HM; He J; Li YL; Yu HY; Ye Z; Zhang LZ; Hu YP
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Sep; 19(5):447-9, 453. PubMed ID: 15169652
[TBL] [Abstract][Full Text] [Related]
15. [Suppression of the antigen-specific T cell immune response by co-immunization with the HBV DNA vaccine and recombinant HBsAg].
Du X; Wang J; Kang Y; Xiao W; Zhao G; Wang B
Wei Sheng Wu Xue Bao; 2009 Jul; 49(7):938-42. PubMed ID: 19873759
[TBL] [Abstract][Full Text] [Related]
16. Poly(propyleneimine) dendrimer and dendrosome mediated genetic immunization against hepatitis B.
Dutta T; Garg M; Jain NK
Vaccine; 2008 Jun; 26(27-28):3389-94. PubMed ID: 18511160
[TBL] [Abstract][Full Text] [Related]
17. Cationic transfersomes based topical genetic vaccine against hepatitis B.
Mahor S; Rawat A; Dubey PK; Gupta PN; Khatri K; Goyal AK; Vyas SP
Int J Pharm; 2007 Aug; 340(1-2):13-9. PubMed ID: 17446015
[TBL] [Abstract][Full Text] [Related]
18. Use of SV40 to immunize against hepatitis B surface antigen: implications for the use of SV40 for gene transduction and its use as an immunizing agent.
Kondo R; Feitelson MA; Strayer DS
Gene Ther; 1998 May; 5(5):575-82. PubMed ID: 9797861
[TBL] [Abstract][Full Text] [Related]
19. Hydrogel-delivered GM-CSF overcomes nonresponsiveness to hepatitis B vaccine through the recruitment and activation of dendritic cells.
Chou HY; Lin XZ; Pan WY; Wu PY; Chang CM; Lin TY; Shen HH; Tao MH
J Immunol; 2010 Nov; 185(9):5468-75. PubMed ID: 20889541
[TBL] [Abstract][Full Text] [Related]
20. Construction of a recombinant plasmid harbouring the glyceraldenyde-3-phosphate dehydrogenase gene of periodic Brugia malayi and observation on DNA immunity.
Fang Z; Tong H; Zhang S; Fang H; Lu S; Xu B
Indian J Med Microbiol; 2012; 30(2):193-7. PubMed ID: 22664436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
